<br />
INTERVENTIONAL<br />
CARDIOLOGY<br />
Abbott supplement • emjreviews.com<br />
INSIDE<br />
Bioresorbable Vascular Scaffolds<br />
as Optimal Treatment for Selected<br />
Patients in our Clinical Practice<br />
BIORESORBABLE VASCULAR SCAFFOLDS AS OPTIMAL<br />
TREATMENT FOR SELECTED PATIENTS IN OUR<br />
CLINICAL PRACTICE<br />
Four Experts Translate Clinical Trial Evidence to the Real World<br />
*Caroline Charles<br />
Scilink Medical Writing, Biarritz, France.<br />
*Correspondence to scilink.mw@gmail.com<br />
Disclosure: Restricted grant from ABBOTT Vascular.<br />
Received: 09.05.16 Accepted: 29.06.16<br />
Citation: EMJ Int Cardiol. 2016;4[Suppl 12]:2-7.<br />
ABSTRACT<br />
Bioresorbable vascular scaffolds (BRS)/bioabsorbable stents are a new and promising generation of<br />
intravascular devices that may potentially circumvent many of the problems associated with permanent<br />
metallic stents <a title="EMJ Int Cardiol. 2016 Suppl 12 page 1" href="http://viewer.zmags.com/publication/4a68a1a8?page=1"> INTERVENTIONAL CARDIOLOGY Abbott supplement • em</a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 2" href="http://viewer.zmags.com/publication/4a68a1a8?page=2"> BIORESORBABLE VASCULAR SCAFFOLDS AS OPTIMAL </a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 3" href="http://viewer.zmags.com/publication/4a68a1a8?page=3"> stents (DES) in terms of reduced acute recoil and</a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 4" href="http://viewer.zmags.com/publication/4a68a1a8?page=4"> disease, bifurcation lesions with two</a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 5" href="http://viewer.zmags.com/publication/4a68a1a8?page=5"> following bench testing and model testing t</a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 6" href="http://viewer.zmags.com/publication/4a68a1a8?page=6"> Another setting in which I use BRS is dif</a>
<a title="EMJ Int Cardiol. 2016 Suppl 12 page 7" href="http://viewer.zmags.com/publication/4a68a1a8?page=7"> have a complete coronary circulation over t</a>